Lupin to acquire portfolio of brands from Anglo-French Drugs -; Industries; Stock jumps over 1.5%

4 Apr 2022 , 12:58 PM

Lupin Ltd stocks rally in today’s market session after the announcement of acquisition of portfolio of brands from Anglo-French Drugs & Industries Limited.

As per regulatory filing, the company informed that it has signed Definitive Agreement with Anglo-French Drugs & Industries Limited for acquiring a portfolio of brands (including all rights and interests associated with such products), to strengthen the Company’s presence in Vitamins, Minerals & Supplements and CNS segments.

On Monday at around 1:03 PM, Lupin was trading at Rs778 apiece up by Rs12.75 or 1.67% on the BSE.